Thioctic acid derivatives as building blocks to incorporate DNA oligonucleotides onto gold nanoparticles

Molecules

Volumn 19, Issue 7, 2014, Pages 10495-10523

  Pérez Rentero, Sónia ^a,b   Grijalvo, Santiago ^a,b   Peñuelas, Guillem ^a   Fàbrega, Carme ^a,b   Eritja, Ramon ^a,b  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Cathepsin; DNA; DNA gold nanoparticle conjugates; Stability; Surface coverage; Thioctic acid; Threoninol

Indexed keywords

GOLD; METAL NANOPARTICLE; OLIGODEOXYRIBONUCLEOTIDE; THIOCTIC ACID;

GOLD; METAL NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; THIOCTIC ACID;

EID: 84904813855     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190710495     Document Type: Article

References (56)

1. Yeh, Y.-C.; Creran, B.; Rotello, V.M. Gold Nanoparticles: Preparation, properties and applications in bionanotechnology. Nanoscale 2012, 4, 1871-1880.
2. Radwan, S.H.; Azzazy, H.M.E. Gold nanoparticles for molecular diagnostics. Expert Rev. Mol. Diagn. 2009, 9, 511-524.
3. Saha, K.; Agasti, S.S.; Kim, C.; Li, X.; Rotello, V.M. Gold nanoparticles in chemical and biological sensing. Chem. Rev. 2012, 112, 2739-2779.
4. Dykman, L.; Khlebtsov, N. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chem. Soc. Rev. 2012, 41, 2256-2282.
5. Doane, T.L.; Burda, C. The unique role of nanoparticles in nanomedicine: Imaging, drug delivery and therapy. Chem. Soc. Rev. 2012, 41, 2885-2911.
6. Giljohann, D.A.; Seferos, D.S.; Daniel, W.L.; Massich, M.D.; Patel, P.C.; Mirkin, C.A. Gold nanoparticles for biology and medicine. Angew. Chem. Int. Ed. 2012, 49, 3280-3294.
7. Llevot, A.; Astruc, D. Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer. Chem. Soc. Rev. 2012, 41, 242-257.
8. Choi, Y.-E.; Kwak, J.-W.; Park, J.W. Nanotechnology for early cancer detection. Sensors 2010, 10, 428-455.
9. Rana, S.; Bajaj, A.; Mout, R.; Rotello, V.M. Monolayer coated gold nanoparticles for delivery applications. Adv. Drug Deliv. Rev. 2012, 64, 200-216.
10. Niemeyer, C.M. Nanoparticles, proteins, and nucleic acids: Biotechnology meets materials science. Angew. Chem. Int. Ed. 2001, 40, 4128-4158.
11. Lévy, R.; Thanh, N.T.K.; Doty, R.C.; Hussain, I.; Nichols, R.J.; Schiffrin, D.J.; Brust, M.; Fernig, D.G. Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J. Am. Chem. Soc. 2004, 126, 10076-10084.
12. Gao, J.; Huang, X.; Liu, H.; Zan, F.; Ren, J. Colloidal stability of gold nanoparticles modified with thiol compounds: Bioconjugation and application in cancer cell imaging. Langmuir 2012, 28, 4464-4471.
13. Goldstein, D.C.; Thordarson, P.; Peterson, J.R. The bioconjugation of redox proteins to novel electrode materials. Aust. J. Chem. 2009, 62, 1320-1327.
14. Wang, H.; Yang, R.; Yang, L.; Tan, W. Nucleic acid conjugated nanomaterials for enhanced molecular recognition. ACS Nano 2009, 3, 2451-2460.
15. Cutler, J.I.; Auyeung, E.; Mirkin, C.A. Spherical nucleic acids. J. Am. Chem. Soc. 2012, 134, 1376-1391.
16. Hu, R.; Zhang, X.-B.; Kong, R.-M.; Zhao, X.-H.; Jiang, J.; Tan, W. Nucleic acid-functionalized nanomaterials for bioimaging applications. J. Mater. Chem. 2011, 21, 16323-16334.
17. Katz, E.; Willner, I. Integrated nanoparticle-biomolecule hybrid systems: Synthesis, properties, and applications. Angew. Chem. Int. Ed. 2004, 43, 6042-6108.
18. Li, X.; Guo, J.; Asong, J.; Wolfert, M.A.; Boons, G.-J. Multifunctional surface modification of gold-stabilized nanoparticles by bioorthogonal reactions. J. Am. Chem. Soc. 2011, 133, 11147-11153.
19. Stobiecka, M.; Hepel, M. Double-shell gold nanoparticle-based DNA-carriers with poly-L-lysine binding surface. Biomaterials 2011, 32, 3312-3321.
20. Cobbe, S.; Connolly, S.; Ryan, D.; Nagle, D.; Eritja, R.; Fitzmaurice, D. DNA-controlled assembly of protein-modified gold nanocrystals. J. Phys. Chem. B 2003, 107, 470-477.
21. Mirkin, C.A.; Letsinger, R.L.; Mucic, R.C.; Storhoff, J.J. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 1996, 382, 607-609.
22. Zhi, L.; Rongchao, J.; Mirkin, C.A.; Letsinger, R.L. Multiplethiol- Anchor capped DNA-gold nanoparticle conjugates. Nucleic Acid Res. 2002, 30, 1558-1562.
23. Chompoosor, A.; Han, G.; Rotello, V.M. Charge dependence of ligand release and monolayer stability of gold nanoparticles by biogenic thiols. Bioconjug. Chem. 2008, 19, 1342-1345.
24. Kang, J.S.; Taton, T.A. Oligothiol graft-copolymer coatings stabilize gold nanoparticles against harsh experimental conditions. Langmuir 2012, 28, 16751-16760.
25. Zhang, G.; Yang, Z.; Lu, W.; Zhang, R.; Huang, Q.; Tian, M.; Li, L.; Liang, D.; Li, C. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009, 30, 1928-1936.
26. Ghann, W.E.; Aras, O.; Fleiter, T.; Daniel, M.-C. Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases. Langmuir 2012, 28, 10398-10408.
27. Oh, E.; Susumu, K.; Blanco-Canosa, J.B.; Medintz, I.L.; Dawson, P.E.; Mattoussi, K. Preparation of stable maleimide-functionalized Au nanoparticles and their use for counting surface ligands. Small 2010, 6, 1273-1278.
28. Dougan, J.A.; Reid, A.K.; Graham, D. Thioctic acid modification of oligonucleotides using an H-phosphonate. Tetrahedron Lett. 2010, 51, 5787-5790.
29. Dougan, J.A.; Karlsson, C.; Smith, W.E.; Graham, D. Enhanced oligonucleotide-nanoparticle conjugate stability using thioctic acid modified oligonucleotides. Nucleic Acid Res. 2007, 35, 3668-3675.
30. Dubowchik, G.M.; Walker, M.A. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs. Pharm. Ther. 1999, 83, 67-123.
31. Trail, P.A.; Willner, D.; Knipe, J.; Henderson, A.J.; Lasch, S.J.; Zoeckler, M.E.; TrailSmith, M.D.; Doyle, T.W.; King, H.D.; Casazza, A.M.; et al. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. Cancer Res. 1997, 57, 100-105.
32. Yan, S.; Sameni, M.; Sloane, B.F. Cathepsin B and human tumor progression. Biol. Chem. 1998, 379, 113-123.
33. Etrych, T.; Strohalm, J.; Chytil, P.; Cernoch, P.; Starovoytova, L.; Pechar, M.; Ulbrich, K. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting. Eur. J. Pharm. Sci. 2011, 42, 527-539.
34. Dubowchik, G.M.; Firestone, R.A.; Padilla, L.; Willner, D.; Hofstead, S.J.; Mosure, K.; Knipe, J.O.; Lasch, S.J.; Trail, P.A. Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: Model studies of enzymatic drug release and antigen-specific in vitro. Bioconjug. Chem. 2002, 13, 855-869.
35. Harada, M.; Sakakibara, H.; Yano, T.; Suzuki, T.; Okuno, S. Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate. J. Control. Release 2000, 69, 399-412.
36. Li, M.; Meares, C.F. Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. Bioconjug. Chem. 1993, 4, 275-283.
37. Hurst, S.J.; Lytton-Jean, A.K.R.; Mirkin, C.A. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal. Chem. 2006, 78, 8313-8318.
38. Becker, C.F.W.; Marsac, Y.; Hazarika, P.; Moser, J.; Goody, R.S.; Niemeyer, C.M. Functional immobilization of the small GTPase Rab6A on DNA-gold nanoparticles by using a site-specifically attached poly(ethylene glycol) linker and thiol place- exchange reaction. ChemBioChem 2007, 8, 32-36.
39. Singh, N.; Agrawal, A.; Leung, A.K.L.; Sharp, P.A.; Bhatia, S.N. Effect of nanoparticle conjugation on gene silencing by RNA interference. J. Am. Chem. Soc. 2010, 132, 8241-8243.
40. Shenhar, R.; Rotello, V.M. Nanoparticles: Scaffolds and building blocks. Acc. Chem. Res. 2003, 36, 549-561.
41. Liu, Y.; Shipton, M.K.; Ryan, J.; Kaufman, E.D.; Franzen, S.; Feldheim, D.L. Synthesis, stability and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal. Chem. 2007, 79, 2221-2229.
42. Barrett, L.; Dougan, J.A.; Faulds, K.; Graham, D. Stable dye-labelled oligonucleotide-nanoparticle conjugates for nucleic acid detection. Nanoscale 2011, 3, 3221-3227.
43. Kashida, H.; Liang, X.; Asanuma, H. Rational design of functional DNA with a non-ribose acyclic scaffold. Curr. Org. Chem. 2009, 13, 1065-1084.
44. Pérez-Rentero, S.; Grijalvo, S.; Ferreira, R.; Eritja, R. Synthesis of oligonucleotides carrying thiol groups using a simple reagent derived from threoninol. Molecules 2012, 17, 10026-10041.
45. Pérez-Rentero, S.; Garibotti, A.V.; Eritja, R. Solid-phase synthesis of oligodeoxynucleotides containing N4-[2-(t-butyldisulfanyl)ethyl]-5- methyl-cytosine moieties. Molecules 2010, 15, 5692-5707.
46. Taton, T.A. Preparation of gold nanoparticle-DNA conjugates. Curr. Protoc. Nucleic Acid Chem. 2002, 12, doi:10.1002/0471142700.nc1202s09.
47. Demers, L.M.; Mirkin, C.A.; Mucic, R.C.; Reynolds, R.A.; Letsinger, R.L.; Elghanian, R.; Viswanadham, G. A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles. Anal. Chem. 2000, 72, 5535-5541.
48. Hill, H.D.; Millstone, J.E.; Banholzer, M.J.; Mirkin, C.A. The role radius of curvature plays in thiolated oligonucleotides loading on gold nanoparticles. ACS Nano 2009, 3, 2, 418-424.
49. Vargas, M.C.; Gianozzi, P.; Selloni, A.; Scoles, G. Coverage-dependent adsorption of CH3S and (CH3S)2 on Au(111): A density functional theory study. J. Phys. Chem. B 2001, 105, 9509-9513.
50. Ionita, P.; Caragheorgheopol, A.; Gilbert, B.C.; Chechik, V. EPR study of a place-exchange reaction on Au nanoparticles: Two branches of a disulfide molecule do not adsorb adjacent to each other. J. Am. Chem. Soc. 2002, 124, 9048-9049.
51. Terrill, R.G.; Postlethwaite, T.A.; Chen, C.-H.; Poon, C.-D.; Terzis, A.; Chen, A.; Hutchison, J.E.; Clark, M.R.; Wignall, G.; Londono, J.D.; et al. Monolayers in three dimensions: NMR, SAXS, thermal, and electron hopping studies of alkanethiol stabilized gold clusters. J. Am. Chem. Soc. 1995, 117, 12537-12548.
52. Letsinger, R.L.; Elghanian, R.; Viswanadham, G.; Mirkin, C.A. Use of a steroid cyclic disulphide anchor in constructing gold nanoparticle- oligonucleotide conjugates. Bioconjug. Chem. 2000, 11, 289-291.
53. Love, J.C.; Estroff, L.A.; Kriebel, J.K.; Nuzzo, R.G.; Whitesides, G.M. Self- Assembled monolayers of thiolates on metals as a form of nanotechnology. Chem. Rev. 2005, 105, 1103-1169.
54. Boal, A.K.; Rotello, V.M. Intra- And intermonolayer hydrogen bonding in amide-functionalized alkanethiol self- Assembled monolayers on gold nanoparticles. Langmuir 2000, 16, 9527-9532.
55. Kratz, F.; Muller, I.A.; Ryppa, C.; Warnecke, A. Prodrug strategies in anticancer chemotherapy. ChemMedChem 2008, 3, 20-53.
56. Gupta, K.C.; Kumar, P.; Bathia, D.; Sharma, A.K. A rapid method for the functionalization of polymer supports for solid phase oligonucleotide synthesis. Nucleos. Nucleot. 1995, 14, 829-832.